ISN Research Collaborative Meeting and 1st International Consensus Meeting on Defining Kidney Failure in Clinical Trials
A two-day meeting is to be held in Vancouver, Canada, from January 31 to February 1, 2020, bringing together members of ISN Research groups, patients, clinicians, clinical trialists, academics, industry, and regulators to establish momentum for international collaborative work in clinical trials and research in kidney disease across the world.
The meeting will introduce current ISN research activities and describe the overall landscape in international clinical research. The core focus of the meeting is to establish the 1st International Definition of Kidney Failure in Clinical Trials Consensus Document, with publication and dissemination to follow.
This is the first attempt by the international nephrology community to identify a reproducible, robust definition of kidney failure for clinical trials, to be used worldwide, in any resource setting. The value of this consensus definition will be to improve consistency and understanding of results in clinical trials. This is a first step toward a long-term goal to improve the evidence-base from which to treat patients with kidney diseases worldwide.
This initiative is part of ISN’s recognition of the importance of clinical research and the need to enhance clinical trials based on established endpoints with international relevance.
